Other Income & Expense
Non-operating Income
Kailera Therapeutics Non-operating Income decreased by 90.1% to $79.00K in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryOther
SignalHigher is better
VolatilityVolatile
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026
How to read this metric
An increase boosts net income but may not be sustainable, while a decrease reflects lower peripheral gains or higher non-core expenses.
Detailed definition
Non-operating income includes gains or losses from activities outside the company's core business, such as interest inco...
Peer comparison
Varies widely by company; peers with large investment portfolios or diverse non-core assets will show higher volatility here.
Metric ID:
cvx_nonoperating_incomeHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $800.00K | $79.00K |
| QoQ Change | — | -90.1% |
| YoY Change | — | -90.1% |
Range$79.00K – $800.00K
Avg YoY Growth-90.1%
Median YoY Growth-90.1%
Non-operating Income at Other Companies
Frequently Asked Questions
- What is Kailera Therapeutics 's non-operating income?
- Kailera Therapeutics (KLRA) reported non-operating income of $79.00K in Q1 2026.
- What does non-operating income mean?
- Income or expenses not related to the company's main business operations.